An Exploratory Clinical Study of TILs in the Treatment of Recurrent / Refractory Non-small Cell Lung Cancer (NSCLC)
Clinical trial NCT04919616 · UNKNOWN
Trial details
- NCT number
- NCT04919616
- Sponsor
- Shanghai OriginCell Therapeutics Co., Ltd.
- Status
- UNKNOWN
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-06-15
- Primary completion
- 2023-06-15
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.